Why is Vimta Labs falling/rising?

As of 25-Jun, Vimta Labs Ltd's stock price is currently at 464.50, reflecting an increase of 1.55, or 0.33%. The stock has been gaining for the last two days, with a total return of 0.85% during this period. However, it has underperformed its sector by 3.04% today. Over the past week, the stock has declined by 2.89%, and in the last month, it has fallen by 4.94%. Despite these short-term declines, the stock has shown impressive long-term performance, with a 91.98% return over the past year, significantly outperforming the benchmark BSE 500, which returned only 3.43%. The company maintains a low debt-to-equity ratio of 0.03, indicating financial stability, and has reported strong operating profit growth.
In the broader market context, while Vimta Labs has faced short-term challenges, the medical equipment sector has gained by 3.37%, suggesting a positive environment for related stocks. The stock's recent performance contrasts with the benchmark, which has shown a positive return of 1.61% over the past week. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 51.33% against the five-day average, which could indicate waning interest among investors despite the company's strong long-term growth prospects. Overall, while Vimta Labs has experienced a recent uptick in price, its short-term performance remains under pressure compared to both its sector and the broader market.